Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Infant Bacterial Therapeutics B IBTB Apr 25, 2025 53.20 -0.56   
 Infrea INFREA Apr 25, 2025 13.05 +1.95   
 Inhalation Sciences ISAB Apr 25, 2025 0.82 -37.97   
 Inission B INISSB Apr 25, 2025 36.30 +1.40   
 Initiator Pharma INIT Apr 25, 2025 6.56 -1.80   
 Insplorion INSP Apr 25, 2025 0.55 +11.61   
 Instalco INSTAL Apr 25, 2025 31.74 +0.51   
 Intea Fastigheter B INTEAB Apr 25, 2025 59.43 +2.38   
 Intea Fastigheter D INTEAD Apr 25, 2025 39.40 +2.31   
 Integrum B INTEGB Apr 25, 2025 13.22 -1.05   
 Intellego Technologies INT Apr 25, 2025 72.00 +3.30   
 International Petroleum Corp. IPCO Apr 25, 2025 140.60 +0.79   
 Intervacc IVACC Apr 25, 2025 0.96 +2.57   
 Intrum INTRUM Apr 25, 2025 32.00 +6.03   
 Invent Medic IMS Apr 25, 2025 0.17 -0.58   
 Investor A INVEA Apr 25, 2025 286.60 +1.42   
 Investor B INVEB Apr 25, 2025 286.15 +1.33   
 INVISIO IVSO Apr 25, 2025 377.00 +1.62   
 Invoicery Group AB FRILAN Apr 25, 2025 5.05 +1.00   
 Inwido INWI Apr 25, 2025 195.00 +3.12   
 Irisity IRIS Apr 25, 2025 0.37 -1.85   
 IRLAB Therapeutics A IRLABA Apr 25, 2025 7.07 +1.00   
 Isofol Medical ISOFOL Apr 25, 2025 1.90 +2.21   
 ITAB Shop Concept ITAB Apr 25, 2025 24.35 -0.81   
 iZafe Group B IZAFEB Apr 25, 2025 0.26 -0.38   
 JLT Mobile Computers JLT Apr 25, 2025 2.32 +16.00   
 JM JM Apr 25, 2025 150.30 -0.73   
 Job Solution Sweden Holding AB (publ) JOBS Apr 25, 2025 31.30 +1.29   
 John Mattson JOMA Apr 25, 2025 60.60 -0.98   
 JonDeTech Sensors JDT Apr 25, 2025 1.70 -6.59   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.